Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125317193 | 12531719 | 3 | F | 20160912 | 20160706 | 20160919 | EXP | TR-ABBVIE-16P-161-1668599-00 | ABBVIE | DUMANLI OZCAN A, OZCAN E, CANAKCI E, ET AL. L-CARNITINE USAGE IN TREATMENT OF ACUTE VALPROIC ACID INTOXICATION. ANETEZI DERG... 2016 JAN 01;24(2):123-125. | 24.00 | YR | F | Y | 0.00000 | 20160919 | OT | COUNTRY NOT SPECIFIED | TR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125317193 | 12531719 | 1 | PS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | U | UNKNOWN | 18081 | |||||||||
125317193 | 12531719 | 2 | C | OLANZAPINE. | OLANZAPINE | 1 | 0 | ||||||||||||
125317193 | 12531719 | 3 | C | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | 0 | ||||||||||||
125317193 | 12531719 | 4 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125317193 | 12531719 | 1 | Suicide attempt |
125317193 | 12531719 | 2 | Product used for unknown indication |
125317193 | 12531719 | 3 | Product used for unknown indication |
125317193 | 12531719 | 4 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125317193 | 12531719 | HO |
125317193 | 12531719 | LT |
125317193 | 12531719 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125317193 | 12531719 | Acidosis | |
125317193 | 12531719 | Altered state of consciousness | |
125317193 | 12531719 | Coma | |
125317193 | 12531719 | Completed suicide | |
125317193 | 12531719 | Condition aggravated | |
125317193 | 12531719 | Drug level increased | |
125317193 | 12531719 | Hypercapnia | |
125317193 | 12531719 | Hypernatraemia | |
125317193 | 12531719 | Hypocalcaemia | |
125317193 | 12531719 | Leukopenia | |
125317193 | 12531719 | Loss of consciousness | |
125317193 | 12531719 | Respiratory depression | |
125317193 | 12531719 | Somnolence | |
125317193 | 12531719 | Tachycardia | |
125317193 | 12531719 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |